Introducing new tuberculosis diagnostics: The impact of Xpert® MTB/RIF testing on case notifications in Nepal

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 5, 2015, Pages 545-551

  Creswell, Jacob ^a   Rai, B ^b   Wali, R ^b   Sudrungrot, S ^b   Adhikari, L M ^b   Pant, R ^c   Pyakurel, S ^d   Uranw, D ^d   Codlin, A J ^a  

^a Stop TB Partnership   (Switzerland)

^b INTERNATIONAL ORGANIZATION FOR MIGRATION   (Switzerland)

^c National Leprosy Control Programme   (Nepal)

^d Eastern Regional Health Directorate Office   (Nepal)

Author keywords

Case detection; Innovation; Notification; Programme evaluation; Tuberculosis; Xpert mtb rif

Indexed keywords

RIFAMPICIN; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MOLECULAR DIAGNOSIS; MYCOBACTERIUM TUBERCULOSIS; NEPAL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS RAPID TEST; CONFIDENCE INTERVAL; INFECTION CONTROL; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPUTUM; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; CONFIDENCE INTERVALS; DISEASE NOTIFICATION; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEPAL; POLYMERASE CHAIN REACTION; QUALITY IMPROVEMENT; RADIOGRAPHY, THORACIC; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84925605603     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0775     Document Type: Article

References (29)

1. World Health Organization. Approaches to improve sputum smear microscopy for tuberculosis diagnosis: expert group meeting report. Geneva, Switzerland: WHO, 2009.
2. Cattamanchi A, Davis J L, Pai M, Huang L, Hopewell P C, Steingart K R. Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol 2010, 48: 2433-2439.
3. Soto A, Solari L, Gotuzzo E, Acinelli R, Vargas D, Van der Stuyft P. Performance of an algorithm based on WHO recommendations for the diagnosis of smear-negative pulmonary tuberculosis in patients without HIV infection. Trop Med Int Health 2011; 16: 424-430.
4. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
5. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
6. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. WHO/HTM/TB/2011.4. Geneva, Switzerland: WHO, 2011.
7. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extra-pulmonary TB in adults and children. Policy update. WHO/HTM/TB/2013.16. Geneva, Switzerland: WHO, 2013.
8. Creswell J, Codlin A J, Andre E, et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis 2014; 14: 2.
9. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014 1; 383: 424-435.
10. Weyer K, Mirzayev F, Migliori G B, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
11. Qin Z Z, Pai M, Van Gemert W, et al How is Xpert MTB/RIF being implemented in 22 high TB burden countries? Eur Respir J 2015; 45: 549-554.
12. Reza L W, Satyanarayna S, Enarson D A, et al. LED-fluorescence microscopy for diagnosis of pulmonary tuberculosis under programmatic conditions in India. PLOS ONE 2013; 8: e75566.
13. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO; 2013.
14. Creswell J, Sahu S, Blok L, Bakker M I, Stevens R, Ditiu L. A multi-site evaluation of innovative approaches to increase tuberculosis case notification: summary results. PLOS ONE 2014; 9: e94465.
15. Theron G, Peter J, Dowdy D, Langley I, Squire S B, Dheda K. Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? Lancet Infect Dis 2014; 14: 527-532.
16. van Cleeff M R A, Kivihya-Ndugga L E, Meme H, Odhiambo J A, Klatser P R. The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya. BMC Infect Dis 2005, 5: 111.
17. Ministry of Health, Department of Health, Government of Myanmar. Report on National TB Prevalence Survey 2009-2010, Myanmar. Yangoon, Myanmar: Ministry of Health, 2011.
18. van't Hoog A H, Meme H K, Laserson K F, et al. Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms. PLOS ONE 2012; 7: e38691.
19. Somashekar N, Chadha V K, Praseeja P, et al. Role of pre-Xpert screening using chest X-ray in early diagnosis of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2014; 18: 1243-1244.
20. Khan M S, Osman D, Sismanidis C, Shah K, Godfrey-Faussett P. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 2007; 369: 1955-1960.
21. Yoon C, Cattamanchi A, Davis J L, et al. Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLOS ONE 2012; 7: e48599.
22. st Conference on Retroviruses and Opportunistic Infections (CROI 2014). Boston, MA, USA, 3-6 March 2014. [Abstract 95].
23. World Health Organization. Definitions and reporting framework for tuberculosis - 2013 revision. Geneva, Switzerland; WHO, 2013.
24. MacPherson P, Houben M, Glynn J R, Corbett E L, Kranzer K. Pre-treatment loss to follow-up in tuberculosis patients in low-and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. Bull World Health Organ 2014; 92: 126-138.
25. World Health Organization. Summary report of the Expert Group Meeting on the use of liquid culture media. Geneva, Switzerland; WHO 2007. http://www.who.int/tb/laboratory/use-of-liquid-tb-culture-summary-report.pdf?ua=1 Accessed February 2015.
26. Royce S, Falzon D, van Weezenbeek C, et al. Multidrug resistance in new tuberculosis patients: burden and implications. Int J Tuberc Lung Dis 2013; 17: 511-513.
27. Blok L, Creswell J, Stevens R H, et al. A pragmatic approach to measuring, monitoring and evaluating interventions for improved tuberculosis case detection. Int Health 2014; 6: 181-188.
28. Squire S B, Ramsay A R, van den Hof S, et al. Making innovations accessible to the poor through implementation research. Int J Tuberc Lung Dis 2011; 15: 862-870.
29. World Health Organization. Sixty-Seventh World Health Assembly. A67/11. Draft global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva, Switzerland: WHO, 2014.